The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation - Image 1

£129.49

Routledge The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

Name: The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation
Brand: Routledge
Price: 129.49 GBP
Availability: InStock

Professional Finance

This is the most expensive it has ever been. Walk away.

£129 today · previous high £129 · all-time low £125

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 52 days · 52 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 52 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £129 (29 days, 55.8%)

Price range: £125 - £129

Price levels: 2 different prices over 52 days

Description

The Price of Global Health is a unique book that describes the pharmaceutical pricing process and its business, economic and social challenges. Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death? The pharmaceutical industry is under unprecedented pressure due to a combination of declining R&D productivity, payer/provider demands for better value and public pressures to show pricing restraint. Rapidly increasing cost of healthcare, shifts from fee-for-service to value-based reimbursement, public pressure on drug pricing and an increasingly vocal medical community have empowered public and private payers worldwide to be more demanding on evidence of value for the prescription drugs that are brought to market. Pharmaceutical companies have often failed to deliver evidence of patient value, as development decision-making is overly focused on speed to FDA approval rather than speed to commercial success by effectively addressing the many “Access Journey” obstacles that typify today’s much changed pharmaceutical environment. This 3rd edition is significantly expanded with ten new chapters and revised and updated throughout to reflect today’s environment. The contents are reorganized to directly address critical pricing and patient access issues. Ed Schoonveld explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. His insights will help a wide range of audiences from healthcare industry professionals to policy makers, consumers, pharmaceutical company leaders and access and pricing professionals to gain a better understanding of this highly complex and emotionally charged field.

Product Specifications

Brand: Routledge
Format: hardcover
ASIN: 0367279401
Category: Books > Subjects > Business, Finance & Law > Professional Finance
Domain: Amazon UK
Release Date: 03 June 2020
Listed Since: 28 November 2019

Barcode

No barcode data available

Routledge The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)

Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

The Right Price: A Value-Based Prescription for Drug Costs

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

The Right Price: A Value-Based Prescription for Drug Costs

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Fundamentals of Market Access for Pharmaceuticals

World Scientific Strategic Marketing Specialty Pharmaceuticals Book

Pharmacoeconomics: From Theory to Practice

Pharmacoeconomics: From Theory to Practice

The Public Financing of Pharmaceuticals: An Economic Approach

Global Issues in Pharmaceutical Marketing

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

Essentials of Pharmacoeconomics: Health Economics and Outcomes Research

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Supply Chain in the Pharmaceutical Industry: Strategic Influences and Supply Chain Responses

Routledge - The Future of Health Economics - Academic Book

Springer - Innovation and Marketing in Pharmaceutical Industry

The 2023 Report on Pharma Contract Sales: World Market Segmentation by City

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)